# DEP-Ru Regimen as a Salvage Therapy for HLH

> **NCT03533790** · PHASE3 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **DRUG:** DEP-Ru

## Key facts

- **NCT ID:** NCT03533790
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2018-06
- **Final completion:** 2021-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03533790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03533790, "DEP-Ru Regimen as a Salvage Therapy for HLH". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03533790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*